Ruxolitinib and Severe COVID-19
- Author:
Rujittika MUNGMUNPUNTIPANTIP
1
;
Viroj WIWANITKIT
Author Information
- Publication Type:Correspondence
- From:Infection and Chemotherapy 2021;53(4):796-796
- CountryRepublic of Korea
- Language:English
- Abstract: no abstract available.
